scholarly journals Atrial fibrillation in athletes: From epidemiology to treatment in the novel oral anticoagulants era

2018 ◽  
Vol 72 (4) ◽  
pp. 269-276 ◽  
Author(s):  
Giuseppe D. Sanna ◽  
Eleonora Gabrielli ◽  
Elena De Vito ◽  
Giuseppe Nusdeo ◽  
Domenico Prisco ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
The Novel

scholarly journals 41 * Electrical cardioversion of atrial fibrillation with the novel oral anticoagulants: a single centre UK-based registry experience

EP Europace ◽  
2014 ◽  
Vol 16 (suppl 3) ◽  
pp. iii16-iii16
Author(s):  
A. Arujuna ◽  
G. Ooues ◽  
A. Abbas ◽  
P. Sivanandarajah ◽  
B. Sidhu ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Oral Anticoagulants ◽  
Electrical Cardioversion ◽  
Novel Oral Anticoagulants ◽  
The Novel ◽  
Single Centre

Cost Effectiveness of Treatments for Stroke Prevention in Atrial Fibrillation: Focus on the Novel Oral Anticoagulants

2013 ◽  
Vol 31 (11) ◽  
pp. 971-980 ◽  
Author(s):  
Charalampos Kasmeridis ◽  
Stavros Apostolakis ◽  
Lars Ehlers ◽  
Lars H. Rasmussen ◽  
Giuseppe Boriani ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Cost Effectiveness ◽  
Stroke Prevention ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
The Novel

Thrombin and Platelets in Pulmonary Hypertension: A Lot More Than Clot

2012 ◽  
Vol 11 (1) ◽  
pp. 19-24
Author(s):  
R. James White
Keyword(s):  
Atrial Fibrillation ◽  
Pulmonary Hypertension ◽  
Venous Thrombosis ◽  
Oral Anticoagulants ◽  
Coagulation Factors ◽  
Novel Oral Anticoagulants ◽  
The Novel

This article is intended to deliver a clinically relevant overview about the role of coagulation factors and platelets in the pathogenesis of pulmonary hypertension. After summarizing the available data with warfarin, some information is provided about the novel oral anticoagulants that were recently approved for atrial fibrillation and may soon be approved for venous thrombosis. The author is hopeful that this information will stimulate investigator interest in this topic and drive us toward meaningful studies about this important aspect of PAH therapy.

scholarly journals EFFICACY AND SAFETY OF THE NOVEL ORAL ANTICOAGULANTS COMPARED TO WARFARIN IN PATIENTS WITH NON VALVULAR ATRIAL FIBRILLATION

2016 ◽  
Vol 67 (13) ◽  
pp. 761
Author(s):  
Ilaria Gagliardi ◽  
Teresa Bruni ◽  
Elisa Rauseo ◽  
Vincenzo Paravati ◽  
Francesco Barilla ◽  
...  
Keyword(s):  
Atrial Fibrillation ◽  
Oral Anticoagulants ◽  
Novel Oral Anticoagulants ◽  
The Novel ◽  
Efficacy And Safety
Sign in / Sign up

Export Citation Format

Share Document